Post-polypectomy scar: comparing four imaging methods to find residual tissue
Official title: Diagnostic Accuracy of White Light Endoscopy, Texture and Color Enhancement Imaging (TXI), Narrow-Band Imaging (NBI) and Artificial Intelligence (GI Genius) for the Detection of Adenomatous Recurrence at Post-Polypectomy Scars: a Prospective, Randomized Crossover, Blinded Study (PRINCESS)
Run by University Hospital Virgen de las Nieves · NCT07874152 · Data updated 2026-11-12
Doctors will test four imaging methods to see which best detects leftover or recurrent tissue at colonoscopy scars after large polyps were removed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 206 (estimated) |
| Sponsor | University Hospital Virgen de las Nieves Academic / other |
| Locations | 2 sites (Granada, Granada and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | December 30, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT07874152 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who had a colorectal lesion ≥15 mm resected by EMR or ESD 3 to 6 months earlier and now are referred for scar review with histology showing adenoma or sessile serrated lesion.
✕Probably not a fit
Patients whose scars show no residual tissue or whose lesions do not benefit from imaging enhancements may receive standard care without additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center study compares high-definition white light endoscopy, TXI, NBI, and a computer-aided detection system for detecting residual or recurrent tissue at post-polypectomy scars. Each scar is evaluated using all four techniques in random order by different experts, with biopsies taken from suspicious areas and histology used as the reference standard. Adults with a recent piecemeal EMR or ESD of colorectal lesions ≥15 mm are eligible, provided they are referred for scar review 3 to 6 months after treatment. The goal is to identify the imaging combination that yields the highest detection accuracy for residual neoplasia. The study is conducted at Hospital Universitario Virgen de las Nieves in Granada, Spain, led by its University Hospital gastroenterology department.
Why it matters
Potential benefit: If successful, the approach could improve accuracy in detecting residual or recurrent tissue, potentially reducing missed recurrences and guiding more effective endoscopic retreatment.
How similar studies have gone: Previous studies suggest that advanced imaging and CADe can improve detection of residual tissue, but head-to-head comparisons among TXI, WLE, NBI, and CADe in post-EMR scars are novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Previous endoscopic resection (endoscopic mucosal resection or endoscopic submucosal dissection) of a colorectal lesion ≥15 mm, performed 3 to 6 months before the surveillance colonoscopy. * Histology of the resected lesion showing an adenoma or a sessile serrated lesion. * Referral for endoscopic review of the post-polypectomy scar. * Signed written informed consent. Exclusion Criteria: * Resected lesion \<15 mm. * Histology of the resected lesion other than adenoma or sessile serrated lesion. * Incomplete previous resection, or uncertainty about the completeness of the previous resection. * Patients who, because of age or comorbidity, are not candidates for endoscopic surveillance. * Failure to complete the study protocol, including biopsy of the scar.
Where it's running
-
Department of Gastroenterology and Hepatology. Virgen de las Nieves University Hospitals
Granada, Granada, Spain Recruiting -
Virgen de las Nieves University Hospital. Department of Gastroenterology and Hepatology
Granada, Granada, Spain Recruiting
Study contacts
- Study coordinator: Eduardo Redondo Cerezo, MD, PhD
- Email: eredondoc@gmail.com
- Phone: +34 657373336
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Noninvasive molecular test for colorectal polyps before colonoscopy
This study tests whether saliva and stool markers can predict the presence of colorectal polyps in adults undergoing colonoscopy.
-
SUBMO for Submucosal Injection in Endoscopic Resection of Colorectal Polyps
This trial tests whether SUBMO®, a hyaluronic acid-based gel with blue dye, can safely and effectively replace saline for submucosal injection during endoscopic removal of colorectal polyps larger than 10 mm.
-
Digital training to improve optical diagnosis of colorectal polyps
This project will test whether a digital training app helps doctors more accurately predict polyp tissue type during colonoscopy for adults who have polyps.
-
Using SCALE-EYE to measure colorectal polyp size accurately and reduce procedure waste
This trial tests whether SCALE-EYE can accurately measure polyp size during screening or surveillance colonoscopy in people aged 55–80 and whether its use can cut down on follow-up procedures and waste.
-
3D imaging during colonoscopy to find high-risk adenomas
This trial tests whether a 3D imaging device used during colonoscopy helps identify patients with high-risk adenomas better than standard 2D imaging.
-
Using AI to predict polyp pathology during colonoscopy
This study is testing whether a new AI tool can help doctors better identify and classify polyps during colonoscopy to improve patient care and reduce unnecessary procedures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.